Lv1
40 积分 2024-10-10 加入
Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries
2天前
已完结
TAILOR: A phase III trial comparing erlotinib with docetaxel as the second-line treatment of NSCLC patients with wild-type (wt) EGFR
5个月前
已关闭
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
5个月前
已完结
皖公网安备34019202002308
